Skip to main content

Table 1 Health and medical conditions recommended for cannabis treatment on 179 identified websites and corresponding conclusions from the National Academies 2017 review

From: A content analysis of internet information sources on medical cannabis

Condition

Percent

NASEM conclusion

Nausea (including from chemotherapy)

26

Conclusive or substantial

Pain

24

(no conclusion)

Epilepsy

23

None or insufficient

Multiple sclerosis

21

Conclusive or substantial

Chronic pain

20

Conclusive or substantial

Anxiety

20

Limited

Appetite loss

19

Limited

Cancer

19

None or insufficient

Glaucoma/Intraocular pressure

15

Ineffective (limited)

Depression

14

Ineffective (limited)

Vomiting (including from chemotherapy)

14

Conclusive or substantial

Chronic Fatigue Syndrome

13

(no conclusion)

Insomnia

13

(no conclusion)

PTSD

13

Limited

Neuropathic pain

11

(no conclusion)

Arthritis (including various forms)

10

(no conclusion)

Inflammation

10

Limited

HIV/AIDS

10

None or insufficient

Muscle spasms

10

(no conclusion)

Drug and alcohol addiction

9

Increased risk (moderate)

  1. Note: NASEM Conclusion indicates determinations by the National Academies of Sciences, Engineering, and Medicine (2017) that there is conclusive or substantial evidence that cannabis or cannabinoids are effective in treatment, conditions for which evidence for effectiveness was limited, conditions with no or insufficient evidence for treatment effectiveness (9%), conditions with evidence for the ineffectiveness of treatment, and conditions with evidence for increased risk due to the use of cannabis